Characterization of human RPE subpopulations at the single cell level
Characterization of human RPE subpopulations at the single cell level
批准号:
10186756
负责人:
Jeffrey H Stern
金额:
$41.23万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-01 至 2023-05-31
关键词:
AdultAffectAgeAge related macular degenerationAnimal ModelAnimalsBioinformaticsBiological AssayBiologyBlindnessCandidate Disease GeneCategoriesCell TransplantationCell modelCell surfaceCellsCharacteristicsClinicalCultured CellsDataDevelopmentDiseaseElderlyEye diseasesFlow CytometryGene ExpressionGene Expression ProfileGenesGoalsHealthHealthcareHeterogeneityHumanImageIn VitroIncidenceIndividualLabelLightLongitudinal StudiesModelingMolecularNonexudative age-related macular degenerationPathogenesisPathway interactionsPhotoreceptorsPilot ProjectsPlayPopulationPopulation HeterogeneityProcessProliferatingRetinaRoleSafetySourceStem Cell DevelopmentStructure of retinal pigment epitheliumSurfaceSurveysTechniquesTestingTherapeuticTimeTranscriptTransplantationUntranslated RNAVisionVisual AcuityWorkcandidate markercell bankcell replacement therapycell typeclinical translationeconomic costeffective therapyepithelial stem cellexperimental studyimprovedin vitro Assayin vivoin vivo evaluationknock-downmonolayernoveloverexpressionpreclinical studypreservationpreventprogenitorprospectiverepairedretina transplantationretinal progenitor cellself-renewalstem cell therapystem cellssubretinal injectionsuccesstranscriptomics
中文摘要
项目摘要/摘要
英文摘要
Project Summary / Abstract
The retinal pigment epithelium (RPE) plays a crucial role in supporting vision through a variety of activities that
maintain retinal health. A loss of RPE cells occurs early in age related macular degeneration (AMD) with a
concomitant loss of vision. AMD is the leading cause of blindness in the elderly and its incidence is expected to
increase as the US population ages, with great associated personal and economic costs. AMD can be divided
into two categories: `dry' AMD constitutes ~90% of cases and `wet' AMD the remaining ~10%. Currently no
effective treatment is available for dry AMD, but stem cell therapy holds great promise to replace the RPE cells
lost in dry AMD pathogenesis. To this end, we have identified an adult RPE stem cell (RPESC) as a potential
source for RPE cell replacement. Our previous work utilizing an animal model of AMD demonstrated the ability
of transplanted RPESC-derived RPE (RPESC-RPE) to rescue vision. We found that a progenitor stage of
RPESC-RPE maturation is more effective than fully differentiated, mature progeny at vision rescue. In this
proposal, we aim to first survey the RPE subpopulations present in the native human RPE layer, including the
RPESC, using single cell transcriptomics (Aim 1) and a cell surface screen (Aim2). In Aim 3, we assess the
cellular and molecular pathways that underlie vision benefit by transplanted RPE vision. In preliminary
experiments using an in vitro integration assay that efficiently evaluates each RPE subpopulation, we found the
RPE progenitor stage integrates more effectively than differentiated RPE progeny. We plan to confirm these in
vitro results and describe integration of individual subpopulations after transplantation in the animal model.
Furthermore, the transcripts that identify the effective RPE subpopulation describe the set of genes that are
associated with vision rescue. We use a bioinformatics approach to identify these genes and then propose
knock-down and overexpression experiments to assess their function in vitro and in vivo. Completion of these
studies will significantly increase our understanding of the RPE at cellular, molecular and functional levels.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Identifying biomarkers of heterogeneity and transplantation efficacy in retinal pigment epithelial cells.
鉴定视网膜色素上皮细胞异质性和移植功效的生物标志物。
DOI:
10.1084/jem.20230913
发表时间:
2023
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
[Farjood,Farhad, Manos,JustineD, Wang,Yue, Williams,AnneL, Zhao,Cuiping, Borden,Susan, Alam,Nazia, Prusky,Glen, Temple,Sally, Stern,JeffreyH, Boles,NathanC]
通讯作者:
Boles,NathanC
Controlled-release Microbeads to Replace Growth Factors in Fetal Bovine Serum
-
批准号:10254493
-
项目类别:
-
资助金额:$22.55万
-
财政年份:2021
-
负责人:Jeffrey H Stern
-
依托单位:
Phase1/2a Clinical Trial of RPESC-derived RPE Transplantation as Therapy for Non-exudative Age-related Macular Degeneration
-
批准号:10440734
-
项目类别:
-
资助金额:$63.84万
-
财政年份:2020
-
负责人:Jeffrey H Stern
-
依托单位:
Phase1/2a Clinical Trial of RPESC-derived RPE Transplantation as Therapy for Non-exudative Age-related Macular Degeneration
-
批准号:10044560
-
项目类别:
-
资助金额:$20.06万
-
财政年份:2020
-
负责人:Jeffrey H Stern
-
依托单位:
Phase1/2a Clinical Trial of RPESC-derived RPE Transplantation as Therapy for Non-exudative Age-related Macular Degeneration
-
批准号:10487569
-
项目类别:
-
资助金额:$63.84万
-
财政年份:2020
-
负责人:Jeffrey H Stern
-
依托单位:
Transplantation of Adult, Tissue-Specific RPE Stem Cells as Therapy for Non-exudative Age-Related Macular Degeneration AMD
-
批准号:9811094
-
项目类别:
-
资助金额:$33.85万
-
财政年份:2019
-
负责人:Jeffrey H Stern
-
依托单位:
SYNAPSES BETWEEN ISOLATED PAIRS OF RETINAL CELLS
-
批准号:3038455
-
项目类别:
-
资助金额:$2.5万
-
财政年份:1986
-
负责人:Jeffrey H Stern
-
依托单位:
SYNAPSES BETWEEN ISOLATED PAIRS OF RETINAL CELLS
-
批准号:3038454
-
项目类别:
-
资助金额:$2.0万
-
财政年份:1985
-
负责人:Jeffrey H Stern
-
依托单位:
海外基金